Neurodegenerative Disorders: Computer – Aided Drug Design, Еxperimental Аpproaches and Mechanisms
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 20 November 2024 | Viewed by 152
Special Issue Editors
Interests: drug design; molecular docking; molecular dynamics; Alzheimer’s disease; immunoinformatics
Special Issues, Collections and Topics in MDPI journals
Interests: antioxidants; antioxidant activity; lipid peroxidation; oxidative stress; reactive oxygen species
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The global impact of neurodegenerative disorders increases every year. Therefore, the need for novel drugs, therapies and prevention is urgent. This Special Issue aims to focus on the application of all available and novel methods, analyses and approaches, including in silico, in vitro, in vivo, ex vivo, etc., in the field of neurodegenerative diseases. We welcome original articles and reviews applying these methods for the identification and development of promising drug candidates, as well as for any intimate mechanism of action or new hypothesis in the battle with neurodegenerative disorders.
Dr. Mariyana Atanasova
Dr. Rumyana Simeonova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative disorders
- drug design
- molecular docking
- Alzheimer’s disease
- pharmacological mechanism
